Valeant Pharmaceuticals

Latest Articles

The Morning Brief: Cooperman on Netflix, First Data and Fees

Stephen Taub September 1, 2016

2016-06-da-hillary-clinton-democratic-nomination-large.jpg

Daily Agenda: Clinton Secures Nomination. What’s Next for the Markets?

Andrew Barber June 7, 2016

The Morning Brief: Managed Futures Funds Weather Turbulence in April

Stephen Taub May 19, 2016

The Morning Brief: At SALT— Heat, Light and a Few Ideas

Stephen Taub May 12, 2016

For Members Only

Valeant’s Winners and Losers

Stephen Taub March 16, 2016

The Morning Brief: Alcoa Trades Expanded Board for Elliott’s Support

Stephen Taub February 2, 2016

Sex-for-Life Testosterone Boost Fueling Safety Concerns: Health

Aggressive Pharma Ads Yield Results — and Complaints

Khadijah M Silver December 4, 2015

Martin Shkreli, Chief Investment Officer of MSMB Capital Management

Drug Wars: The Battle to Put a Lid on Rising Prices

Khadijah M Silver November 25, 2015

The Morning Brief: Marcato’s McGuire Exits NCR Board

Stephen Taub November 13, 2015

The Morning Brief: Valeant Slips as Investors Bail

Stephen Taub November 12, 2015

The Morning Brief: Pershing Square Plans Conference Call on Valeant

Stephen Taub October 28, 2015

Daily Agenda: The Week Ahead, October 26 – 31, 2015

Andrew Barber October 24, 2015

Hedge Fund Manager Kyle Bass Declares War on Drug Prices

Jess Delaney October 22, 2015

For Members Only

Tourbillon Thrives on a Heady Mix of PR and Performance

Stephen Taub June 9, 2015

For Members Only

Tiger Bloc’s Biggest Holdings: Actavis, CDK and JD.com

Stephen Taub June 4, 2015

For Members Only

Jana Partners Absorbs Another Monthly Loss

Stephen Taub May 4, 2015

For Members Only

Viking Global Breaks with Tiger Cubs and Bets on Health Care

Stephen Taub April 30, 2015

For Members Only

Activists Turn Out a Strong First Quarter

Stephen Taub April 21, 2015

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.28.00 build:2026-09-14 Login